MOSCHETTA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 10.093
EU - Europa 2.832
AS - Asia 1.537
SA - Sud America 409
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 14.899
Nazione #
US - Stati Uniti d'America 10.071
CN - Cina 753
SE - Svezia 616
IT - Italia 585
SG - Singapore 531
RU - Federazione Russa 525
BR - Brasile 383
DE - Germania 316
UA - Ucraina 204
FI - Finlandia 186
GB - Regno Unito 186
ID - Indonesia 66
FR - Francia 58
HK - Hong Kong 50
NL - Olanda 40
VN - Vietnam 37
IE - Irlanda 34
BE - Belgio 32
IN - India 22
TR - Turchia 19
AT - Austria 18
CA - Canada 12
CZ - Repubblica Ceca 11
IQ - Iraq 8
ZA - Sudafrica 7
AR - Argentina 6
UZ - Uzbekistan 6
BD - Bangladesh 5
CO - Colombia 5
IR - Iran 5
JP - Giappone 5
LT - Lituania 5
MA - Marocco 5
AL - Albania 4
EC - Ecuador 4
MX - Messico 4
PE - Perù 4
PK - Pakistan 4
TN - Tunisia 4
VE - Venezuela 4
KR - Corea 3
PL - Polonia 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BN - Brunei Darussalam 1
CH - Svizzera 1
ES - Italia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.899
Città #
Fairfield 1.653
Woodbridge 1.136
Houston 792
Ashburn 764
Chandler 732
Seattle 607
Cambridge 602
Wilmington 531
Nyköping 493
Jacksonville 476
Ann Arbor 464
Singapore 296
Bari 220
Lawrence 190
Roxbury 188
Nanjing 181
Beijing 134
New York 127
Dearborn 125
Des Moines 109
Inglewood 97
Princeton 89
San Diego 75
Boardman 71
Jakarta 63
Shenyang 49
Helsinki 48
Hong Kong 48
London 46
Hebei 43
Santa Clara 43
Brooklyn 37
Los Angeles 36
Dong Ket 34
Dublin 34
Jiaxing 33
Moscow 32
Nanchang 32
Brussels 31
San Giovanni Teatino 30
Nuremberg 27
Munich 26
Cressa 24
Guangzhou 23
Tianjin 23
Falkenstein 22
Frankfurt am Main 22
Changsha 20
Hefei 19
Pescara 17
Redwood City 17
Rome 17
São Paulo 17
Jinan 15
Kunming 15
Paris 15
Council Bluffs 14
Belo Horizonte 13
Indianapolis 13
Manduria 11
Rio de Janeiro 10
Brno 9
Cerignola 9
Düsseldorf 9
Shanghai 9
Toronto 9
Catania 8
Ningbo 8
Porto Alegre 8
Pune 8
San Mateo 8
Hounslow 7
Istanbul 7
Norwalk 7
Wuhan 7
Zhengzhou 7
Portsmouth 6
Shenzhen 6
Vienna 6
Acton 5
Brasília 5
Chiswick 5
Fortaleza 5
Goiânia 5
Jinhua 5
Lubbock 5
Mumbai 5
Ostuni 5
Prescot 5
Tashkent 5
Toyonaka 5
Andria 4
Brescia 4
Curitiba 4
Fuzhou 4
Manassas 4
Naples 4
Osasco 4
Pelotas 4
Recife 4
Totale 11.405
Nome #
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators 162
Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate 140
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa 135
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours 134
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil 130
Atherosclerosis: lessons from LXR and the intestine. 127
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19 126
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 124
Role of oleic acid in the gut-liver axis: From diet to the regulation of its synthesis via Stearoyl-CoA desaturase 1 (SCD1) 124
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations 123
Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse 122
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 121
Nuclear receptors in regenerating liver and hepatocellular carcinoma 119
Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis 118
Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice 117
Sindrome metabolica e lavoro 116
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. 115
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes 114
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice 113
Adenomatous polyposis coli (APC)-induced apoptosis of HT29 colorectal cancer cells depends on mitochondrial oxidative metabolism 113
Bile acids lower triglyceride levels via a pathway involving FXR, SHP and SREBP1c 111
Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame? 111
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. 109
Extra virgin olive oil: Lesson from nutrigenomics 107
The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids 106
Pathophysiology of cholesterol gallstone disease 105
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. 105
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis 105
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 104
Hepatic-specific PPARa-FGF21 action in NAFLD 104
PGC-1α induced browning promotes involution and inhibits lactation in mammary glands 103
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice 102
Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2 102
Water handling and aquaporins in bile formation: recent advances and research trends 102
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open-label pilot trial. 101
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome 100
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari 99
A phylogenetic survey of biliary lipids in vertebrates 98
A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia 98
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 98
The FXR-FGF19 Gut-Liver Axis as a Novel "hepatostat" 97
Intestinal ecology in the metabolic syndrome 97
Welcoming Foxa2 in the bile acid entourage 97
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption 96
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio 96
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin 96
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. 96
The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors 94
Preface: a special issue on nuclear receptors with a special view on the molecular basis of disease. 92
Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study 92
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants 92
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure 92
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis 92
Bile acids and colon cancer: Solving the puzzle with nuclear receptors 92
The emerging discipline of precision cooking: a suitable tool for the precision nutrition 92
A translational view on the biliary lipid secretory network 91
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR? 91
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 91
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer 90
Primary sclerosing cholangitis: updates in diagnosis and therapy. 89
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis 89
null 88
Changes of gallbladder and gastric dynamics in patients with acute hepatitis A 88
Intestinal nuclear receptors in HDL cholesterol metabolism. 87
Hepatic Niemann Pick C1-like 1: the canalicular side of the coin 86
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link 86
Nuclear receptors and cholesterol metabolism in the intestine 86
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD) 86
Linking transcription to physiology in lipidomics 85
Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice 84
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis 83
Pathways of cholesterol crystallization in model bile and native bile 83
Tissue-specific actions of FXR in metabolism and cancer. 83
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis. 83
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. 83
Potential role of the vitamin D receptor in control of cholesterol levels. 82
Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles 81
Nuclear bile acid receptor FXR protects against intestinal tumorigenesis 81
Micellar lipid composition profoundly affects LXR-dependent cholesterol transport across CaCo2 cells 81
Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms 81
null 81
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1 81
null 80
Nuclear bile acid receptor FXR as pharmacological target: are we there yet? 80
Extra-virgin olive oil from Apulian cultivars and intestinal inflammation 80
LA SINDROME METABOLICA NEGLI ADDETTI ALLA PESCA MARITTIMA 80
Cholesterol gallstone disease 79
Taurodeoxycholate cytotoxic and sphingomyelin protective effects in isolated human colon mucosa 79
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice 78
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes 78
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 78
Asymmetric distribution of phosphatidylcholine and sphyngomyelin between micellar and vesicular phases: potential implication for canalicular bile formation 77
Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction 77
Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome 77
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 77
null 76
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver 76
Severe impairment of postprandial cholecystokinin release and gallbladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR 74
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 74
From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease 73
Totale 9.669
Categoria #
all - tutte 75.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020340 0 0 0 0 0 0 0 0 0 0 252 88
2020/20212.306 149 147 155 156 427 119 242 164 185 283 157 122
2021/20221.594 148 187 31 65 59 191 51 90 113 125 236 298
2022/20232.116 331 224 138 158 223 304 17 256 342 22 51 50
2023/2024855 52 170 37 52 68 211 33 53 7 29 41 102
2024/20252.531 151 30 320 146 105 366 519 380 229 261 24 0
Totale 15.683